Skip to main navigation Skip to search Skip to main content

A Phase 1, Open-Label, Multicenter, Non-comparative Pharmacokinetics and Safety Study of Intravenous Isavuconazonium Sulfate in Pediatric Patients

Project: Research

Project Details

StatusFinished
Effective start/end date07/14/17 → 07/13/20

Funding

  • Astellas Pharma US Incorporated: $20,390.00